N-DESPROPYL GAMITHROMYCIN 10,13-IMINO ETHER
UNII 5E4MWT7T42

Substance Identification & Data

This profile provides standardized clinical and technical data for N-despropyl Gamithromycin 10,13-imino Ether, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5E4MWT7T42.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 145414-17-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5E4MWT7T42

CAS Registry Number

145414-17-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

N-DESPROPYL GAMITHROMYCIN 10,13-IMINO ETHER

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C37H66N2O12

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

GULQTHHZACCSIH-ULJZSMOKSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

129627264

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C[C@]12[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]3C[C@](OC)(C)[C@@H](O)[C@H](C)O3)[C@H](C)[C@@H](O[C@H]4[C@H](O)[C@@H](N(C)C)C[C@@H](C)O4)[C@](C)(O)C[C@@H](C)/N=C(\O1)/[C@H](C)[C@H]2O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for N-despropyl Gamithromycin 10,13-imino Ether. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

N-DESPROPYL GAMITHROMYCIN 10,13-IMINO ETHER

Systematic Nomenclature

11,16-DIOXA-2-AZABICYCLO(11.2.1)HEXADEC-1-EN-10-ONE, 8-((2,6-DIDEOXY-3-C-METHYL-3-O-METHYL-.ALPHA.-L-RIBO-HEXOPYRANOSYL)OXY)-12-ETHYL-5,14-DIHYDROXY-3,5,7,9,13,15-HEXAMETHYL-6-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-, (1Z,3R,5R,6R,7S,8S,9R,12R,13S,14R,15S)-

SYS

1Z,3R,5R,6R,7S,8S,9R,12R,13S,14R,15S)-8-((2,6-DIDEOXY-3-C-METHYL-3-O-METHYL-.ALPHA.-L-RIBO-HEXOPYRANOSYL)OXY)-12-ETHYL-5,14-DIHYDROXY-3,5,7,9,13,15-HEXAMETHYL-6-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-11,16-DIOXA-2-AZABICYCLO(11.2.1)HEXADEC-1-EN-10-ONE

SYS

External Clinical & Regulatory Resources

Previous UNII5E4EZ79T7G

Next UNII5E4O85D8T2